Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 1
1977 2
1978 2
1979 1
1980 2
1981 1
1982 2
1983 1
1984 5
1985 2
1987 2
1990 1
1991 1
1992 1
1993 1
1994 2
1997 1
1998 1
1999 1
2000 2
2002 1
2003 1
2005 1
2006 1
2007 2
2008 1
2009 2
2010 1
2011 1
2012 4
2013 5
2015 3
2016 1
2017 4
2018 3
2019 1
2020 2
2021 5
2022 1
2023 2
2024 5
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for martel n
Search for Mertel N instead (3 results)
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense.
Bosch M, Sánchez-Álvarez M, Fajardo A, Kapetanovic R, Steiner B, Dutra F, Moreira L, López JA, Campo R, Marí M, Morales-Paytuví F, Tort O, Gubern A, Templin RM, Curson JEB, Martel N, Català C, Lozano F, Tebar F, Enrich C, Vázquez J, Del Pozo MA, Sweet MJ, Bozza PT, Gross SP, Parton RG, Pol A. Bosch M, et al. Among authors: martel n. Science. 2020 Oct 16;370(6514):eaay8085. doi: 10.1126/science.aay8085. Science. 2020. PMID: 33060333 Free article.
IFN-γ licenses normal and pathogenic ALPK1/TIFA pathway in human monocytes.
Martin A, Caron S, Marcotte M, Bronnec P, Garneret E, Martel N, Maalouf G, Sève P, Saadoun D, Jamilloux Y, Henry T. Martin A, et al. Among authors: martel n. iScience. 2024 Dec 10;28(1):111563. doi: 10.1016/j.isci.2024.111563. eCollection 2025 Jan 17. iScience. 2024. PMID: 39868044 Free PMC article.
Pro-ferroptotic lipids as key control points for caveola formation and disassembly.
Wu Y, Lim YW, McMahon KA, Martel N, Rae J, Lo HP, Gao Y, Tillu V, Larsson E, Lundmark R, Levic DS, Bagnat M, Lim J, Fairlie DP, Pol A, Collins BM, Ariotti N, Hall TE, Parton RG. Wu Y, et al. Among authors: martel n. Cell Rep. 2025 Jun 24;44(6):115789. doi: 10.1016/j.celrep.2025.115789. Epub 2025 Jun 4. Cell Rep. 2025. PMID: 40478736 Free article.
Determinants of substance use patterns in patients with narcolepsy type 1: A multi-center comparative cross-sectional study.
Peter-Derex L, Fort E, Putois B, Martel N, Ricordeau F, Bastuji H, Arnulf I, Barateau L, Bourgin P, Dauvilliers Y, Debs R, Dodet P, Dudoignon B, Franco P, Hartley S, Lambert I, Lecendreux M, Leclair-Visonneau L, Léger D, Lemesle-Martin M, Léotard A, Leu-Semenescu S, Limousin N, Lopez R, Meslier N, Micoulaud-Franchi JA, Charley-Mocana C, d'Ortho MP, Philip P, Ruppert E, de La Tullaye S, Brigandet M, Charbotel B, Mazza S, Rolland B. Peter-Derex L, et al. Among authors: martel n. Sleep Med. 2025 May;129:148-166. doi: 10.1016/j.sleep.2025.02.037. Epub 2025 Feb 26. Sleep Med. 2025. PMID: 40024108 Free article.
Effort/reward imbalance and comorbidities burden in academic and professional careers of patients with narcolepsy type 1.
Peter-Derex L, Fort E, Putois B, Martel N, Ricordeau F, Bastuji H, Arnulf I, Barateau L, Bourgin P, Dauvilliers Y, Debs R, Dodet P, Dudoignon B, Franco P, Hartley S, Lambert I, Lecendreux M, Leclair-Visonneau L, Léger D, Lemesle-Martin M, Léotard A, Leu-Semenescu S, Limousin N, Lopez R, Meslier N, Micoulaud-Franchi JA, Charley-Mocana C, d'Ortho MP, Philip P, Ruppert E, de La Tullaye S, Brigandet M, Margier J, Rolland B, Charbotel B, Mazza S. Peter-Derex L, et al. Among authors: martel n. J Clin Sleep Med. 2025 Jun 1;21(6):983-997. doi: 10.5664/jcsm.11598. J Clin Sleep Med. 2025. PMID: 39943847
85 results